Answers are grounded in this paper and cite their sources.
These results demonstrate that CRPC cells employ multiple mechanisms to mediate apoptosis evasion through BCL2 signaling, suggesting this pathway is critical for survival. This study provides a strong preclinical rationale for developing therapeutic strategies to target antiapoptotic BCL2 signaling in combination with AR antagonists to improve treatment options for patients with advanced prostate cancer.
No takes yet. Share an insight, caveat, or question.
Pilling et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: